Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Financial Statements
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Financial Overview
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s market cap is currently $200.69M. The company's EPS TTM is $-0.29; its P/E ratio is -9.26; Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 42.01M | $ 71.76M | $ 58.61M | $ 50.38M | $ 41.15M |
| Gross Profit | $ 12.99M | $ 44.25M | $ 35.17M | $ 28.47M | $ 22.67M |
| Operating Income | $ -20.58M | $ 12.43M | $ 8.65M | $ 9.84M | $ 7.19M |
| EBITDA | $ -7.28M | $ 20.84M | $ 14.89M | $ 15.40M | $ 13.09M |
| Net Income | $ -19.93M | $ 7.55M | $ 4.76M | $ 6.08M | $ 4.25M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.67M | $ 760.00K | $ 2.17M | $ 27.09M | $ 19.46M |
| Total Assets | $ 304.13M | $ 298.62M | $ 265.90M | $ 163.10M | $ 116.83M |
| Total Debt | $ 84.65M | $ 80.38M | $ 70.04M | $ 15.15M | $ 6.49M |
| Net Debt | $ 82.97M | $ 79.62M | $ 67.87M | $ -11.62M | $ -7.81M |
| Total Liabilities | $ 139.39M | $ 177.15M | $ 153.26M | $ 57.54M | $ 42.27M |
| Stockholders' Equity | $ 124.68M | $ 121.47M | $ 112.64M | $ 105.56M | $ 74.55M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.81M | $ -28.11M | $ -117.95M | $ -33.81M | $ -21.71M |
| Operating Cash Flow | $ 7.22M | $ 13.73M | $ -5.34M | $ 2.95M | $ -3.28M |
| Investing Cash Flow | $ -27.82M | $ -25.89M | $ -72.90M | $ -26.97M | $ -4.49M |
| Financing Cash Flow | $ 21.50M | $ 10.75M | $ 53.33M | $ 36.82M | $ 20.22M |
Currency in PLN